RYTM
Rhythm Pharmaceuticals Announces Marketing Authorisation of IMCIVREE setmelanotide in Great Britain
Tuesday, September 21, 2021 1 min read
Key Takeaway: Rhythm Pharmaceuticals Announces Marketing Authorisation of IMCIVREE setmelanotide in Great Britain
Full Press Release Details
Rhythm Pharmaceuticals Announces Marketing Authorisation of IMCIVREE setmelanotide in Great Britain.